Champions Oncology (CSBR) Minority Interest (2025 - 2026)

Champions Oncology (CSBR) posted quarterly Minority Interest of $129000.0 for Q2 2026, up 35.79% quarter-over-quarter from $95000.0 in Q1 2026.

Champions Oncology (CSBR) Minority Interest (2025 - 2026) Analysis & Trends

Champions Oncology's Minority Interest history runs 2 years deep, the most recent figure standing at $129000.0 for Q2 2026.

In Q2 2026, Minority Interest changed N/A year-over-year to $129000.0; the TTM figure through Apr 2026 stood at $129000.0 (changed N/A YoY), while the FY2026 annual figure was $129000.0, changed N/A from the prior year.
Minority Interest for Q2 2026 stood at $129000.0, up from $95000.0 in the prior quarter.
The five-year high for Minority Interest was $129000.0 in Q2 2026, with the low at $30000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	138.04 Bn	130.19 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.58 Bn	77.59 Bn	3.93 Bn
3	Argenx Se	64.52 Bn	59.34 Bn	1.37 Bn
4	Moderna	56.52 Bn	51.38 Bn	52.00 Mn
5	BeOne Medicines	42.04 Bn	36.94 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	30.67 Bn	27.36 Bn	992.69 Mn
7	Insmed	27.27 Bn	26.11 Bn	358.27 Mn
8	BioNTech SE	27.14 Bn	8.75 Bn	668.28 Mn
9	Royalty Pharma	27.12 Bn	26.28 Bn	-
10	Champions Oncology	72.48 Mn	72.48 Mn	7.03 Mn

Download Data